![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 38/26 | (2006.01) |
A61P 3/10 | (2006.01) | ||
A61P 7/12 | (2006.01) | ||
A61P 9/00 | (2006.01) | ||
A61P 9/04 | (2006.01) | ||
A61P 9/10 | (2006.01) | ||
A61P 13/12 | (2006.01) | ||
A61P 43/00 | (2006.01) | ||
A61K 47/02 | (2006.01) | ||
A61K 47/10 | (2017.01) |
(11) | Patento numeris | 3423082 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 17710160.7 |
Europos patento paraiškos padavimo data | 2017-03-03 | |
(97) | Europos patento paraiškos paskelbimo data | 2019-01-09 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-08-04 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/EP2017/054990 |
Data | 2017-03-03 |
(87) | Numeris | WO 2017/149112 |
Data | 2017-09-08 |
(30) | Numeris | Data | Šalis |
16158739 | 2016-03-04 | EP | |
16173917 | 2016-06-10 | EP | |
16001329 | 2016-06-13 | EP | |
201715401651 | 2017-01-09 | US |
(72) |
RASMUSSEN, Søren , DK
KVIST, Kajsa , DK
|
(73) |
Novo Nordisk A/S ,
Novo Allé, 2880 Bagsværd,
DK
|
(54) | LIRAGLUTIDE IN CARDIOVASCULAR CONDITIONS |
LIRAGLUTIDE IN CARDIOVASCULAR CONDITIONS |